The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Shifting from the single to the multitarget paradigm in drug discovery
Open accessAbstract
Increasing evidence that several drug compounds exert their effects through interactions with multiple targets is boosting the development of research fields that challenge the data reductionism approach. In this article, we review and discuss the concepts of drug repurposing, polypharmacology, chemogenomics, phenotypic screening and highthroughput in vivo testing of mixture-based libraries in an integrated manner. These research fields offer alternatives to the current paradigm of drug discovery, from a one target–one drug model to a multiple-target approach. Furthermore, the goals of lead identification are being expanded accordingly to identify not only ‘key’ compounds that fit with a single-target ‘lock’, but also ‘master key’ compounds that favorably interact with multiple targets (i.e. operate a set of desired locks to gain access to the expected clinical effects).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Einfluss der Configuration auf die Wirkung der Enzyme
Fischer, E. (1894) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.18940270364 · Cited by 1,835
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Chen, C. Y.-C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015939 · Cited by 806
Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
Cheng, T., Li, Q., Zhou, Z., Wang, Y., & Bryant, S. H. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9322-0 · Cited by 574
Recognizing Pitfalls in Virtual Screening: A Critical Review
Scior, T., Bender, A., Tresadern, G., Medina-Franco, J. L., Martínez-Mayorga, K., Langer, T., Cuanalo-Contreras, K., & Agrafiotis, D. K. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200528d · Cited by 438
Self-citationDrug repurposing from an academic perspective
Oprea, T. I., Bauman, J. E., Bologa, C. G., Buranda, T., Chigaev, A., Edwards, B. S., Jarvik, J. W., Gresham, H. D., Haynes, M. K., Hjelle, B., et al. (2011) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2011.10.002 · Cited by 364
Chemical space as a source for new drugs
Reymond, J.-L., van Deursen, R., Blum, L. C., & Ruddigkeit, L. (2010) · MedChemComm · doi:10.1039/c0md00020e · Cited by 347
Keynote review: Structural biology and drug discovery
Congreve, M., Murray, C. W., & Blundell, T. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03484-7 · Cited by 338
Pinilla, C., Appel, J. R., Blanc, P., & Houghten, R. A. (1992) · PubMed · Cited by 326
Self-citationOpen PHACTS: semantic interoperability for drug discovery
Williams, A. J., Harland, L., Groth, P., Pettifer, S., Chichester, C., Willighagen, E. L., Evelo, C. T., Blomberg, N., Ecker, G., Goble, C., et al. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.016 · Cited by 321
In silico repositioning of approved drugs for rare and neglected diseases
Ekins, S., Williams, A. J., Krasowski, M. D., & Freundlich, J. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.016 · Cited by 288
Koutsoukas, A., Simms, B., Kirchmair, J., Bond, P. J., Whitmore, A. V., Zimmer, S., Young, M. P., Jenkins, J. L., Glick, M., Glen, R. C., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.011 · Cited by 287
Drug repurposing: far beyond new targets for old drugs
Oprea, T. I., & Mestres, J. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9390-1 · Cited by 285
Mixture-Based Synthetic Combinatorial Libraries
Houghten, R. A., Pinilla, C., Appel, J. R., Blondelle, S. E., Dooley, C. T., Eichler, J., Nefzi, A., & Ostresh, J. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990174v · Cited by 256
Self-citationState-of-the-art in ligand-based virtual screening
Ripphausen, P., Nisius, B., & Bajorath, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.011 · Cited by 240
Databases on food phytochemicals and their health promoting effects
Scalbert, A., Andres-Lacueva, C., Arita, M., Kroon, P., Manach, C., Urpi-Sarda, M., & Wishart, D. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf200591d · Cited by 211
Medicinal chemistry of target family-directed masterkeys
Müller, G. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02781-8 · Cited by 207
Identifying mechanism-of-action targets for drugs and probes
Gregori-Puigjané, E., Setola, V., Hert, J., Crews, B. A., Irwin, J. J., Lounkine, E., Marnett, L., Roth, B. L., & Shoichet, B. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204524109 · Cited by 182
Integrating Virtual Screening and Combinatorial Chemistry for Accelerated Drug Discovery
Lopez-Vallejo, F., Caulfield, T., Martinez-Mayorga, K., A. Giulianotti, M., Nefzi, A., A. Houghten, R., & L. Medina-Franco, J. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795767866 · Cited by 170
Visualization of the Chemical Space in Drug Discovery
Medina-Franco, J., Martinez-Mayorga, K., Giulianotti, M., Houghten, R., & Pinilla, C. (2008) · Current Computer Aided-Drug Design · doi:10.2174/157340908786786010 · Cited by 161
Self-citationStructure‐Based Approaches to Target Fishing and Ligand Profiling
Rognan, D. (2010) · Molecular Informatics · doi:10.1002/minf.200900081 · Cited by 154
Nature or nurture: Let food be your epigenetic medicine in chronic inflammatory disorders
Szic, K. S. V., Ndlovu, ’. N., Haegeman, G., & Berghe, W. V. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.029 · Cited by 149
Tsai, T.-Y., Chang, K.-W., & Chen, C. Y. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9438-9 · Cited by 135
Expanding the medicinally relevant chemical space with compound libraries
López-Vallejo, F., Giulianotti, M. A., Houghten, R. A., & Medina‐Franco, J. L. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.04.001 · Cited by 134
Self-citationChemical informatics and target identification in a zebrafish phenotypic screen
Laggner, C., Kokel, D., Setola, V., Tolia, A., Lin, H., Irwin, J. J., Keiser, M. J., Cheung, C. Y. J., Minor, D. L., Roth, B. L., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.732 · Cited by 126
Comparative Analysis of Pharmacophore Screening Tools
Sanders, M. P. A., Barbosa, A. J. M., Zarzycka, B. A., Nicolaes, G. A. F., Klomp, J. P. G., de Vlieg, J., & Río, A. D. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci2005274 · Cited by 118
Houghten, R. A., Pinilla, C., Giulianotti, M. A., Appel, J. R., Dooley, C. T., Nefzi, A., Ostresh, J. M., Yu, Y., Maggiora, G. M., Medina‐Franco, J. L., et al. (2007) · Journal of Combinatorial Chemistry · doi:10.1021/cc7001205 · Cited by 117
Self-citationThe importance of GRAS to the functional food and nutraceutical industries
Burdock, G. A., Carabin, I. G., & Griffiths, J. C. (2006) · Toxicology · doi:10.1016/j.tox.2006.01.012 · Cited by 112
The prince and the pauper. A tale of anticancer targeted agents
Dueñas‐González, A., García‐López, P., Herrera, L. A., Medina‐Franco, J. L., González‐Fierro, A., & Candelaria, M. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-82 · Cited by 103
Self-citationComplex phenotypic assays in high-throughput screening
Clemons, P. A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.002 · Cited by 102
Public Domain Databases for Medicinal Chemistry
Nicola, G., Liu, T., & Gilson, M. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300501t · Cited by 100
Molecular Scaffold Analysis of Natural Products Databases in the Public Domain
Yongye, A. B., Waddell, J., & Medina‐Franco, J. L. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12011 · Cited by 94
Self-citationDrug Repurposing and the Medicinal Chemist
Aubé, J. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300114c · Cited by 74
Open Access High Throughput Drug Discovery in the Public Domain: A Mount Everest in the Making
Roy, A., McDonald, P. R., Sittampalam, S., & Chaguturu, R. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110792927757 · Cited by 72
Lauro, G., Romano, A., Riccio, R., & Bifulco, G. (2011) · Journal of Natural Products · doi:10.1021/np100935s · Cited by 72
Drug profiling: knowing where it hits
Merino, A., Bronowska, A. K., Jackson, D., & Cahill, D. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.06.006 · Cited by 71
Identification of Pim Kinases as Novel Targets for PJ34 with Confounding Effects in PARP Biology
Antolín, A. A., Jalencas, X., Yélamos, J., & Mestres, J. (2012) · ACS Chemical Biology · doi:10.1021/cb300317y · Cited by 69
Medina‐Franco, J. L., Yongye, A. B., Pérez‐Villanueva, J., Houghten, R. A., & Martínez‐Mayorga, K. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200281v · Cited by 60
Self-citationCheminformatic/bioinformatic analysis of large corporate databases: Application to drug repurposing
Loging, W., Rodriguez‐Esteban, R., Hill, J., Freeman, T. C., & Miglietta, J. J. (2011) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2011.06.004 · Cited by 50
Freely Accessible Databases of Commercial Compounds For High- Throughput Virtual Screenings
Barbosa, A. J. M., & Río, A. D. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612800166710 · Cited by 49
Maggiora, G. M. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9447-8 · Cited by 46
Accessing target information by virtual parallel screening—The impact on natural product research
Rollinger, J. M. (2008) · Phytochemistry Letters · doi:10.1016/j.phytol.2008.12.002 · Cited by 45
Medina‐Franco, J. L., Martínez‐Mayorga, K., Peppard, T. L., & Río, A. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050798 · Cited by 44
Self-citationJacoby, E. (2011) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.11 · Cited by 41
Armishaw, C. J., Singh, N. P., Medina‐Franco, J. L., Clark, R. J., Scott, K. C. M., Houghten, R. A., & Jensen, A. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071183 · Cited by 38
Self-citationYongye, A. B., & Medina‐Franco, J. L. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3002606 · Cited by 24
Self-citationPerspectives on the Discovery of Small-Molecule Modulators for Epigenetic Processes
Lu, Q., Quinn, A. M., Patel, M. P., Semus, S. F., Graves, A. P., Bandyopadhyay, D., Pope, A. J., & Thrall, S. H. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112437763 · Cited by 24
PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery
Carrascosa, M. C., López-Massaguer, O., & Mestres, J. (2012) · Molecular Informatics · doi:10.1002/minf.201200070 · Cited by 19
Montolio, M., Gregori‐Puigjané, E., Pineda, D., Mestres, J., & Navarro, P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301055g · Cited by 13
Computational methods for the discovery of mood disorder therapies
López-Vallejo, F., Peppard, T. L., Medina‐Franco, J. L., & Martínez‐Mayorga, K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.637106 · Cited by 9
Self-citation
Cited by
Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2
Caesar, L. K., & Cech, N. B. (2019) · Natural Product Reports · doi:10.1039/c9np00011a · Cited by 881
Tsubaki, M., Tomii, K., & Sese, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty535 · Cited by 688
Network Pharmacology Approach for Medicinal Plants: Review and Assessment
Noor, F., Tahir ul Qamar, M., Ashfaq, U. A., Albutti, A., Alwashmi, A. S. S., & Aljasir, M. A. (2022) · Pharmaceuticals · doi:10.3390/ph15050572 · Cited by 540
Salehi, B., Zakaria, Z. A., Gyawali, R., Ibrahim, S. A., Rajkovic, J., Shinwari, Z. K., Khan, T., Sharifi-Rad, J., Ozleyen, A., Turkdonmez, E., et al. (2019) · Molecules · doi:10.3390/molecules24071364 · Cited by 523
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Metadata
- Authors
- Medina-Franco, J. L., Giulianotti, M. A., Welmaker, G. S., & Houghten, R. A.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 18
- Issue
- 9-10
- Pages
- 495-501
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1988452823
- Cited by
- 483
- References
- 53
- FWCI
- 48.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.